Newsroom

Press Release

NeoGenomics Schedules its Q1 2017 Earnings Release for April 26, 2017

NeoGenomics and Definiens Enter Into Agreement to Develop Novel Assays for Clinical Trials & Clinical Testing

NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016

NeoGenomics Schedules its Q4 and Full Year 2016 Earnings Release for February 22, 2017

NeoGenomics Closes $150 Million Senior Credit Facility

NeoGenomics Reports 142% Revenue Growth to $60.8 Million and a Record $9.6 Million in Cash Flow from Operations in the Third Quarter of 2016

NeoGenomics Schedules its Q3 2016 Earnings Release for October 26, 2016

NeoGenomics Reports 159% Revenue Growth to $63.1 Million and Strong Gains in Profitability in the Second Quarter of 2016

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients